Gossamer Bio Total Assets

Gossamer Bio (GOSS) currently reports a total assets of $77M as of June 2026. That compares with $240M in the prior-year period — down 68.1% year over year. Use the charts on this page to explore Gossamer Bio's total assets history and peer comparisons.

Gossamer Bio's total assets decreased from $240M to $77M — a 68.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gossamer Bio reported $77M in total assets as of June 2026. That compares with $240M in the prior-year period — down 68.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $77M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gossamer Bio, and consider following GOSS for alerts when major investors trade the stock.

Gossamer Bio is classified in the Healthcare sector. On total assets, it currently shows $77M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GOSS with unrelated industries.